These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8457454)

  • 1. A sclerodermatous syndrome with unusual features following prolonged occupational exposure to organic solvents.
    Bottomley WW; Sheehan-Dare RA; Hughes P; Cunliffe WJ
    Br J Dermatol; 1993 Feb; 128(2):203-6. PubMed ID: 8457454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerodermatous syndrome after occupational exposure to herbicides--response to systemic steroids.
    Dunnill MG; Black MM
    Clin Exp Dermatol; 1994 Nov; 19(6):518-20. PubMed ID: 7889679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic sclerosis and organic solvents: early diagnosis in industry.
    Garcia-Zamalloa AM; Ojeda E; Gonzalez-Beneitez C; Goni J; Garrido A
    Ann Rheum Dis; 1994 Sep; 53(9):618. PubMed ID: 7979602
    [No Abstract]   [Full Text] [Related]  

  • 4. [Occupational systemic sclerosis in men].
    Zachariae H; Bjerring P; Søndergaard KH; Halkier-Sørensen L
    Ugeskr Laeger; 1997 Apr; 159(18):2687-9. PubMed ID: 9173631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors.
    Calvani N; Silvestris F; Dammacco F
    Ann Ital Med Int; 2001; 16(3):175-8. PubMed ID: 11692907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic sclerosis secondary to occupational exposure.
    Owens GR; Medsger TA
    Am J Med; 1988 Jul; 85(1):114-6. PubMed ID: 3389373
    [No Abstract]   [Full Text] [Related]  

  • 7. Progressive systemic sclerosis associated with exposure to trichloroethylene.
    Lockey JE; Kelly CR; Cannon GW; Colby TV; Aldrich V; Livingston GK
    J Occup Med; 1987 Jun; 29(6):493-6. PubMed ID: 3612322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs].
    de la Espriella J; Crickx B
    Ann Dermatol Venereol; 1991; 118(12):948-53. PubMed ID: 1724723
    [No Abstract]   [Full Text] [Related]  

  • 9. Raynaud's phenomenon in medical laboratory workers who work with solvents.
    Purdie GL; Purdie DJ; Harrison AA
    J Rheumatol; 2011 Sep; 38(9):1940-6. PubMed ID: 21677001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Occupational and environmental factors and systemic connective tissue diseases].
    Angelutsa PA; Shcherbak EA; Pozmogova IA; Ignatova AV
    Gig Tr Prof Zabol; 1991; (8):16-8. PubMed ID: 1794698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Should systemic sclerosis be recognised as an occupational disease in Switzerland?
    Schmid M; Grolimund Berset D; Krief P; Zyska Cherix A; Danuser B; Rinaldo M
    Swiss Med Wkly; 2020 Feb; 150():w20193. PubMed ID: 32083706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of occupational exposure with features of systemic sclerosis.
    Marie I; Menard JF; Duval-Modeste AB; Joly P; Dominique S; Bravard P; Noël D; Gehanno JF; Bubenheim M; Benichou J; Levesque H
    J Am Acad Dermatol; 2015 Mar; 72(3):456-64. PubMed ID: 25582539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Occupational scleroderma due to organic solvent exposure].
    Tibon-Fisher O; Heller E; Ribak J
    Harefuah; 1992 Apr; 122(8):530-2, 551. PubMed ID: 1398326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents.
    Povey A; Guppy MJ; Wood M; Knight C; Black CM; Silman AJ
    Arthritis Rheum; 2001 Mar; 44(3):662-5. PubMed ID: 11263781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired dyschromatopsia among petrochemical industry workers exposed to benzene.
    Lee EH; Eum KD; Cho SI; Cheong HK; Paek do M
    Neurotoxicology; 2007 Mar; 28(2):356-63. PubMed ID: 16806479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Practical and disputable aspects of the effect of benzene-containing organic solvents exemplified by the case of hairy cell leukemia].
    Byczkowska Z; Prazanowski M; Zielińska-Jankiewicz K
    Med Pr; 1988; 39(3):206-11. PubMed ID: 3226289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scleroderma-like disease following occupational exposure to organic solvents.
    Altomonte A; Zoli A; Galossi A; Mancusa L; Mirone L; Magnavita N; Federico F; Magaro M
    Clin Rheumatol; 1996 Jul; 15(4):416-7. PubMed ID: 8853181
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immune disorders and chronic exposure to organic solvents. Case-control study in the operators who are in organic synthesis laboratories].
    Vegna F; Laddeca EN; Mineo AA; Trapani E; Vegna V
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):544-5. PubMed ID: 18409823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized morphea-like scleroderma occurring in people exposed to organic solvents.
    Yamakage A; Ishikawa H
    Dermatologica; 1982 Sep; 165(3):186-93. PubMed ID: 6215270
    [No Abstract]   [Full Text] [Related]  

  • 20. Is occupational organic solvent exposure a risk factor for scleroderma?
    Nietert PJ; Sutherland SE; Silver RM; Pandey JP; Knapp RG; Hoel DG; Dosemeci M
    Arthritis Rheum; 1998 Jun; 41(6):1111-8. PubMed ID: 9627022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.